Katsumoto Y, Maruyama N, Nakamura M, Shingai T, Maruyama K, Nakaguchi K, Furukawa J, Okajima S, Sue F, Fukunaga H, Ikenaga M, Sekimoto K
Dept. of Surgery, Suita Municipal Hospital.
Gan To Kagaku Ryoho. 2001 Oct;28(11):1688-91.
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) as the tracer of glucose metabolism was performed to identify a postoperative recurrent lesion of rectal cancer. A 66-year-old-man underwent trans-sacral local resection of the rectum for rectal cancer in 1992. A local recurrent mass was discovered, and abdomino-perineal resection of the rectum was performed in 1999. The serum CEA level increased gradually August in 2000, but there was no sign of recurrence on CT or MRI. FDG-PET was performed to reveal a presacral recurrent lesion. Total pelvic evisceration combined with resection of the sacrum, and a bilateral ureterostomy were performed in April 2001. The beneficial role of FDG-PET in the diagnosis of the postoperative local recurrence of rectal cancer is emphasized.
采用以18F-氟脱氧葡萄糖(FDG)作为葡萄糖代谢示踪剂的正电子发射断层扫描(PET)来识别直肠癌术后复发病变。一名66岁男性于1992年因直肠癌接受了经骶骨直肠局部切除术。发现局部复发性肿块,并于1999年进行了直肠腹会阴切除术。2000年8月血清癌胚抗原(CEA)水平逐渐升高,但CT或MRI上未见复发迹象。进行FDG-PET检查以发现骶前复发病变。2001年4月进行了全盆腔脏器清除术联合骶骨切除术及双侧输尿管造口术。强调了FDG-PET在直肠癌术后局部复发诊断中的有益作用。